Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07211061 · ClinicalTrials.gov registry record · Phase 4
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
A Phase 4 study of Gingivitis, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT07211061: Completed Phase 4 study of Gingivitis, sponsored by Procter and Gamble.
NCT07211061 is a Phase 4 study of Gingivitis that has completed, run by Procter and Gamble. The registered enrollment target is 69 participants, below the 234-participant average among 25 other Gingivitis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07211061, a Phase 4 study of Gingivitis, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Each subject will be randomly assigned to one of two treatment products. The regimen group will be asked to brush 2x a day in using a power brush (2 minutes of brushing), followed by using 20 ml of mouth rinse for 30 seconds for 6 weeks. The negative control group will be asked to brush 2x a day using a manual toothbrush in their customary manner for 6 weeks. Oral Soft Tissue (OST) assessments, gingivitis and plaque measurements will be taken at 4 time-points: Baseline (BL); Week 1; Week 3; and Week 6.
Primary Outcome
Gingival Bleeding Index- evaluation of bleeding from gingival tissue, score from 0-2
Conditions Studied
Interventions
- DRUG Stannous Fluoride Dentifrice
- DRUG Sodium Fluoride Dentifrice
- DEVICE electric toothbrush
- DRUG Cetylpyridinium Chloride (CPC)
- DEVICE manual toothbrush
Study Locations (1)
Nevada
- Bio-Sci Research (Out of Business) - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2011-09-21 |
| Est. Completion | 2011-11-10 |
| Phase | Phase 4 |
What the finished NCT07211061 record still lists
NCT07211061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 234-participant average among 25 other Gingivitis trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 5 interventions - of which Stannous Fluoride Dentifrice is the first listed.
NCT07211061 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT07211061 about?
NCT07211061 is a clinical study titled "A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods". Subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Each subject will be randomly assigned to one of two treatment products. The regimen group will be asked to brush 2x a day in using a power brush (2 minutes of brushing), followed by using 20 ml of mouth rinse ...
What is the current status of trial NCT07211061?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2011-09-21. Estimated completion is 2011-11-10.
What conditions does trial NCT07211061 study?
This clinical trial studies the following conditions: Gingivitis.
What interventions are being tested in trial NCT07211061?
The interventions under investigation include: Stannous Fluoride Dentifrice (DRUG), Sodium Fluoride Dentifrice (DRUG), electric toothbrush (DEVICE), Cetylpyridinium Chloride (CPC) (DRUG), manual toothbrush (DEVICE).
Who is sponsoring clinical trial NCT07211061?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07211061 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07211061's enrollment target sits among peer trials
69 21st of 25 higher than 5 of 25 other Gingivitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing Gingivitis and Plaque From a Marketed Toothpaste
ACTIVE NOT RECRUITING · Phase 4
-
Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste
COMPLETED · Phase 4
-
Imaging-based Assessment of Oral Biofilm and Gingival Health
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI